Literature DB >> 19221342

Embracing ecology to limit antimicrobial resistance.

Lindsay Nicolle1, John M Conly, Noni MacDonald.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19221342      PMCID: PMC2638035          DOI: 10.1503/cmaj.081587

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  11 in total

Review 1.  Controlling antimicrobial resistance. An integrated action plan for Canadians.

Authors: 
Journal:  Can Commun Dis Rep       Date:  1997-11

2.  Routine practices and additional precautions for preventing the transmission of infection in health care.

Authors: 
Journal:  Can Commun Dis Rep       Date:  1999-07

3.  Antimicrobial resistance: a deadly burden no country can afford to ignore.

Authors:  David Birnbaum
Journal:  Can Commun Dis Rep       Date:  2003-09-15

Review 4.  Controlled trials to improve antibiotic utilization: a systematic review of experience, 1984-2004.

Authors:  Thomas A Parrino
Journal:  Pharmacotherapy       Date:  2005-02       Impact factor: 4.705

Review 5.  Antibiotic use and population ecology: how you can reduce your "resistance footprint".

Authors:  David M Patrick; James Hutchinson
Journal:  CMAJ       Date:  2009-02-17       Impact factor: 8.262

6.  René Dubos: a harbinger of microbial resistance to antibiotics.

Authors:  C L Moberg
Journal:  Microb Drug Resist       Date:  1996       Impact factor: 3.431

Review 7.  Antimicrobial resistance in Canada.

Authors:  John Conly
Journal:  CMAJ       Date:  2002-10-15       Impact factor: 8.262

8.  The impact of antimicrobial resistance on health and economic outcomes.

Authors:  Sara E Cosgrove; Yehuda Carmeli
Journal:  Clin Infect Dis       Date:  2003-05-16       Impact factor: 9.079

Review 9.  Clinical and economic burden of antimicrobial resistance.

Authors:  Lisa L Maragakis; Eli N Perencevich; Sara E Cosgrove
Journal:  Expert Rev Anti Infect Ther       Date:  2008-10       Impact factor: 5.091

Review 10.  Interventions to improve antibiotic prescribing practices for hospital inpatients.

Authors:  P Davey; E Brown; L Fenelon; R Finch; I Gould; G Hartman; A Holmes; C Ramsay; E Taylor; M Wilcox; P Wiffen
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19
View more
  3 in total

1.  Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection?--results of a randomized controlled pilot trial.

Authors:  Jutta Bleidorn; Ildikó Gágyor; Michael M Kochen; Karl Wegscheider; Eva Hummers-Pradier
Journal:  BMC Med       Date:  2010-05-26       Impact factor: 8.775

2.  Population-level interventions to reduce the development and transmission of community-associated antimicrobial resistance: A perspective from the National Collaborating Centre for Infectious Diseases.

Authors:  Margaret Fast; Kelly Bunzeluk
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

3.  Microbiological quality of water from the rivers of Curitiba, Paraná State, Brazil, and the susceptibility to antimicrobial drugs and pathogenicity of Escherichia coli.

Authors:  Melissa Giowanella; Angela Bozza; Patricia do Rocio Dalzoto; Jair Alves Dionísio; Sumaia Andraus; Edson Luiz Gomes Guimarães; Ida Chapaval Pimentel
Journal:  Environ Monit Assess       Date:  2015-10-06       Impact factor: 2.513

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.